The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. (vol 51, pg 2826, 2002)

被引：0
|
作者：
Stitt, A
Gardiner, TA
Alderson, NL
Canning, P
Frizzell, N
Duffy, N
Boyle, C
Januszewski, AS
Chachich, M
Baynes, JW
Thorpe, SR
机构：
来源：
DIABETES | 2003年 / 52卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 27 条
  • [1] The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes
    Stitt, A
    Gardiner, TA
    Anderson, NL
    Canning, P
    Frizzell, N
    Duffy, N
    Boyle, C
    Januszewski, AS
    Chachich, M
    Baynes, JW
    Thorpe, SR
    DIABETES, 2002, 51 (09) : 2826 - 2832
  • [2] The AGE/ALE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes
    Stitt, AN
    Gardiner, TA
    Canning, P
    Frizzell, N
    Alderson, NL
    Januszewski, AF
    Baynes, JW
    Thorpe, SR
    DIABETES, 2002, 51 : A202 - A202
  • [3] The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats
    Alderson, NL
    Chachich, ME
    Youssef, NN
    Beattie, RJ
    Nachtigal, M
    Thorpe, SR
    Baynes, JW
    KIDNEY INTERNATIONAL, 2003, 63 (06) : 2123 - 2133
  • [4] Tenilsetam, a new AGE inhibitor, prevents early retinopathy in experimental diabetes
    Lin, J
    Alt, A
    Lochnit, G
    Bretzel, RG
    Hammes, HP
    DIABETES, 2000, 49 : A171 - A172
  • [5] Prostatic stromal microenvironment and experimental diabetes (vol 50, pg 51, 2006)
    Ribeiro, D. L.
    Caldeira, E. J.
    Candido, E. M.
    Manzato, A. J.
    Taboga, S. R.
    Cagnon, V. H.
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2006, 50 (02): : 159 - 159
  • [6] Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity (vol 43, pg 496, 2002)
    Gu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (03) : 822 - 822
  • [7] Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. (vol 25, pg 1499, 2002)
    McGowan, K
    Thomas, W
    Moran, A
    DIABETES CARE, 2003, 26 (02) : 553 - 553
  • [8] Age at onset and the risk of proliferative retinopathy in type 1 diabetes (vol 33, pg 1315, 2010)
    Hietala, K.
    Harjutsalo, V
    Forsblom, C.
    Summanen, P.
    Groop, P-H
    DIABETES CARE, 2011, 34 (04) : 1068 - 1068
  • [9] Effect of high fluoride and low protein on tooth matrix development in goats (vol 35, pg 51, 2002)
    Wang, JD
    Hong, JH
    Li, JP
    Guo, YH
    Zhang, JF
    Hao, JH
    FLUORIDE, 2002, 35 (02) : 142 - +
  • [10] Human resistin gene, obesity, and type 2 diabetes:: mutation analysis and population study (vol 51, pg 860, 2002)
    Sentinelli, F
    Romeo, S
    Arca, M
    Filippi, E
    Leonetti, F
    Banchieri, M
    Di Mario, U
    Baroni, MG
    DIABETES, 2002, 51 (06) : 1992 - 1992
123